Boston Scientific Announces Agreement to Acquire Cortex, Inc.
November 4, 2024
Boston Scientific Corporation entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company, to complement its electrophysiology portfolio with Cortex’s diagnostic mapping technology for complex atrial fibrillation. Cortex’s OptiMap System uses a basket catheter and proprietary algorithm to identify atrial fibrillation triggers outside the pulmonary veins, which is intended to support more targeted ablation strategies.
- Buyers
- Boston Scientific Corporation
- Targets
- Cortex, Inc.
- Sellers
- Ajax Health
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Boston Scientific Investment Agreement with Exclusive Option to Acquire Farapulse, Inc.
September 21, 2020
Medical Devices
Boston Scientific Corporation signed an investment agreement that includes an exclusive option to acquire Farapulse, Inc., a privately held developer of pulsed field ablation technology for atrial fibrillation and other cardiac arrhythmias. Farapulse’s system uses irreversible electroporation (pulsed electric fields) to ablate heart tissue without thermal energy. The platform is investigational and not available for sale.
-
Boston Scientific Acquires Axonics, Inc.
November 15, 2024
Medical Devices
Boston Scientific agreed to acquire Axonics, a medical technology company focused on urinary and bowel dysfunction, for $71 per share in cash, valuing the equity at approximately $3.7 billion. The boards approved the transaction, which was expected to close in the first half of 2024, and Boston Scientific later announced the acquisition closed on November 15, 2024.
-
Philips Agrees to Acquire SpectraWAVE to Expand AI-Enabled Coronary Imaging and Physiology Portfolio
December 15, 2025
Medical Devices
Philips has agreed to acquire SpectraWAVE, a Bedford, Massachusetts-based developer of AI-enabled vascular imaging and coronary physiology assessment tools. The deal is intended to strengthen Philips’ image-guided therapy business by adding SpectraWAVE’s HyperVue Imaging System and X1-FFR software for intravascular imaging and angio-derived fractional flow reserve assessment.
-
Axion BioSystems Acquires CytoSMART Technologies
March 21, 2022
Medical Devices
Axion BioSystems has acquired Netherlands-based CytoSMART Technologies, a developer of kinetic live-cell imaging systems and AI-powered image analysis tools. The acquisition expands Axion's product portfolio and capabilities in live-cell imaging to support research in stem cell biology, immuno-oncology, cell-based therapies, and drug discovery.
-
VME Acquires Cortex Process Equipment
October 6, 2021
Industrial Services
VME has acquired Cortex Process Equipment to add field-service capabilities and custom surface equipment expertise to its engineering and fabrication offerings. The deal brings Cortex’s on-site diagnostics, installation and commissioning services into VME’s portfolio, enabling end-to-end project execution for well-site customers.
-
Castle Biosciences Acquires Cernostics
October 19, 2021
Healthcare Services
Castle Biosciences (Nasdaq: CSTL) has completed the acquisition of Cernostics, Inc., a Pittsburgh-based developer of the TissueCypher spatial biology and AI-driven image analysis platform, for approximately $30 million in initial consideration plus up to $50 million in performance-based milestones. The deal brings the TissueCypher Barrett's Esophagus Assay into Castle's portfolio, expanding the company's diagnostics capabilities into the gastrointestinal and oncology markets and adding an estimated ~$1 billion to Castle's U.S. TAM.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.